Atopic dermatitis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 14: Line 14:
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inherited
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inherited
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired
! colspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
| rowspan="5" |Associated factors
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
|-
|-
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated factors
! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
Line 50: Line 50:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Incidence is highest during infancy and early childhood.
* Incidence is highest during infancy and early childhood.
| align="center" style="background:#F5F5F5;" |
* Family history of atopic dermatitis or other [[atopy]]
* Personal history of [[atopy]] ([[asthma]], [[allergic rhinitis]], [[food allergy]])
* Active and passive exposure to tobacco
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 89: Line 85:
* Psoriasiform hyperplasia
* Psoriasiform hyperplasia
* Dyskeratosis
* Dyskeratosis
| align="center" style="background:#F5F5F5;" |
* Family history of atopic dermatitis or other [[atopy]]
* Personal history of [[atopy]] ([[asthma]], [[allergic rhinitis]], [[food allergy]])
* Active and passive exposure to tobacco
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Hayfever  
* Hayfever  
Line 100: Line 100:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |Any
| align="center" style="background:#F5F5F5;" |Any
| align="center" style="background:#F5F5F5;" |
* Contact with allergens in the past 1-2 days
* Positive family history
| align="center" style="background:#F5F5F5;" |May be multiple after 1-2 days of exposure
| align="center" style="background:#F5F5F5;" |May be multiple after 1-2 days of exposure
| align="center" style="background:#F5F5F5;" | Erythematous well-demarcated papules
| align="center" style="background:#F5F5F5;" | Erythematous well-demarcated papules
Line 118: Line 115:
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |
* Contact with allergens in the past 1-2 days
* Positive family history
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Prevention by avoidance
* Prevention by avoidance
Line 127: Line 127:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |Any, more occupational exposure  
| align="center" style="background:#F5F5F5;" |Any, more occupational exposure  
| align="center" style="background:#F5F5F5;" |
* Cumulative exposure to irritants
| align="center" style="background:#F5F5F5;" |Usually single immediately after the exposure
| align="center" style="background:#F5F5F5;" |Usually single immediately after the exposure
| align="center" style="background:#F5F5F5;" | Well-demarcated red patch with a glazed surface
| align="center" style="background:#F5F5F5;" | Well-demarcated red patch with a glazed surface
Line 146: Line 144:
* Intraepidermal vesicles or bullae
* Intraepidermal vesicles or bullae
* Necrosis of keratinocytes
* Necrosis of keratinocytes
| align="center" style="background:#F5F5F5;" |
* Cumulative exposure to irritants
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Negative hypersensitivity tests
* Negative hypersensitivity tests
Line 155: Line 155:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | Any, onset during the infancy and peak during 3rd-4th decades
| align="center" style="background:#F5F5F5;" | Any, onset during the infancy and peak during 3rd-4th decades
| align="center" style="background:#F5F5F5;" |
* Stress
* Cold, dry weather can cause flare ups
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 180: Line 176:
* Psoriasiform hyperplasia
* Psoriasiform hyperplasia
* Neutrophils at the margins
* Neutrophils at the margins
| align="center" style="background:#F5F5F5;" |
* Stress
* Cold, dry weather can cause flare ups
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Super infection with bacteria and candida
* Super infection with bacteria and candida
Line 191: Line 191:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | Any, 2 peaks of onset 30-39 years and 50-59 years
| align="center" style="background:#F5F5F5;" | Any, 2 peaks of onset 30-39 years and 50-59 years
| align="center" style="background:#F5F5F5;" |
* Smoking
* Skin trauma
* Alcohol abuse
* Stress
* Cold weather
* Vitamin D deficiency
* Drugs
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales
| align="center" style="background:#F5F5F5;" | Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales
Line 215: Line 207:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |
* Smoking
* Skin trauma
* Alcohol abuse
* Stress
* Cold weather
* Vitamin D deficiency
* Drugs
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
Line 223: Line 223:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | Any, peak at 30-50 years of age
| align="center" style="background:#F5F5F5;" | Any, peak at 30-50 years of age
| align="center" style="background:#F5F5F5;" |
* Emotional stress
* Sleep disturbances
* Dry weather
* Sweating
* Excessive dryness
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Lichenified and erythematous, pruritic exudative plaque, and excoriations
| align="center" style="background:#F5F5F5;" | Lichenified and erythematous, pruritic exudative plaque, and excoriations
Line 246: Line 240:
* Thick granular zone
* Thick granular zone
* Acanthosis  
* Acanthosis  
| align="center" style="background:#F5F5F5;" |
* Emotional stress
* Sleep disturbances
* Dry weather
* Sweating
* Excessive dryness
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Sexual dysfunction
* Sexual dysfunction
Line 259: Line 259:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | Usually in infancy
| align="center" style="background:#F5F5F5;" | Usually in infancy
| align="center" style="background:#F5F5F5;" |
* Dry and cold weather
* Increased risk of atopic diseases including asthma, alllergic rhinitis and atopic dermatitis
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 284: Line 281:
* Thick stratum corneum  
* Thick stratum corneum  
* Basket-weave pattern of stratum corneum
* Basket-weave pattern of stratum corneum
| align="center" style="background:#F5F5F5;" |
* Dry and cold weather
* Increased risk of atopic diseases including asthma, alllergic rhinitis and atopic dermatitis
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Increased risk for atopy, including asthma, allergies, and atopic dermatitis
* Increased risk for atopy, including asthma, allergies, and atopic dermatitis
Line 292: Line 292:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | Any,  two peaks, 6th-7th  decade of life in males and 2nd-3rd decade of life in females
| align="center" style="background:#F5F5F5;" | Any,  two peaks, 6th-7th  decade of life in males and 2nd-3rd decade of life in females
| align="center" style="background:#F5F5F5;" |
* Temperature changes (particularly winter)
* Emotional stress
* Dry skin
* Environmental irritants
* Recent surgery
* Medications like topical antibiotic creams and isotretinoin
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
Line 316: Line 309:
* Spongiosis
* Spongiosis
* Perivascular lymphocytic infiltrates, with eosinophils and occasional neutrophils
* Perivascular lymphocytic infiltrates, with eosinophils and occasional neutrophils
| align="center" style="background:#F5F5F5;" |
* Temperature changes (particularly winter)
* Emotional stress
* Dry skin
* Environmental irritants
* Recent surgery
* Medications like topical antibiotic creams and isotretinoin
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Superinfection with ''staphylococcus aureus''
* Superinfection with ''staphylococcus aureus''
Line 325: Line 325:
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | Affects neonates
| align="center" style="background:#F5F5F5;" | Affects neonates
| align="center" style="background:#F5F5F5;" |
* Atopic diseases including food allergy and strong family history of asthma, atopic dermatitis and allergic rhinitis
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 360: Line 358:
* Dyskeratosis,  
* Dyskeratosis,  
* Dermal inflammatory infiltrate including neutrophils and eosinophils
* Dermal inflammatory infiltrate including neutrophils and eosinophils
| align="center" style="background:#F5F5F5;" |
* Atopic diseases including food allergy and strong family history of asthma, atopic dermatitis and allergic rhinitis
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
** Systemic and skin superinfections  
** Systemic and skin superinfections  
Line 371: Line 371:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated factors
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/
Multiple
Multiple
Line 384: Line 383:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated factors
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
|-
|-
Line 411: Line 411:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | Any, peak among children >5 years of age and young adults
| align="center" style="background:#F5F5F5;" | Any, peak among children >5 years of age and young adults
| align="center" style="background:#F5F5F5;" |
* Often asymptomatic
* Tender or pruritic skin lesions
* Self resolve within 2 months
* Immunocompetent patients present with extensive and severe infections
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 432: Line 427:
* Keratinocytes containing eosinophilic inclusion bodies (Henderson-Paterson bodies)
* Keratinocytes containing eosinophilic inclusion bodies (Henderson-Paterson bodies)
* H&E stain - inwards indentation of the epidermis  
* H&E stain - inwards indentation of the epidermis  
| align="center" style="background:#F5F5F5;" |
* Often asymptomatic
* Tender or pruritic skin lesions
* Self resolve within 2 months
* Immunocompetent patients present with extensive and severe infections
| align="center" style="background:#F5F5F5;" | mMlluscum contagiosum
| align="center" style="background:#F5F5F5;" | mMlluscum contagiosum


Line 441: Line 441:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |
* Positive family history
| align="center" style="background:#F5F5F5;" |Multiple
| align="center" style="background:#F5F5F5;" |Multiple
| align="center" style="background:#F5F5F5;" | Erythematous papular lesions
| align="center" style="background:#F5F5F5;" | Erythematous papular lesions
Line 454: Line 452:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |
* Positive family history
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
Line 462: Line 462:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | Any, mean age of disease onset is 2nd-4th decade
| align="center" style="background:#F5F5F5;" | Any, mean age of disease onset is 2nd-4th decade
| align="center" style="background:#F5F5F5;" |
* Intermittent pruritic papules and vesicles
* Associated small intestine celiac disease with villous atrophy and crypt hyperplasia
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 484: Line 481:
* Sub-epidermal blisters containing neutrophils, eosinophils, and fibrin  
* Sub-epidermal blisters containing neutrophils, eosinophils, and fibrin  
* Sub-epidermal vacuolization  
* Sub-epidermal vacuolization  
| align="center" style="background:#F5F5F5;" |
* Intermittent pruritic papules and vesicles
* Associated small intestine celiac disease with villous atrophy and crypt hyperplasia
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Abdominal bloating, pain, diarrhea, or constipation
* Abdominal bloating, pain, diarrhea, or constipation
Line 495: Line 495:
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | Seen almost exclusively in males in infancy
| align="center" style="background:#F5F5F5;" | Seen almost exclusively in males in infancy
| align="center" style="background:#F5F5F5;" |
* Blleeding: severe thrombocytopenia,
* Eczema - similar to atopic dermatitis
* Recurrent sino-pulmonary infections
* Opportunistic infections.
* Autoimmune diseases
* Malignancies
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 527: Line 520:
* Epidermal psoriasiform [[hyperplasia]]
* Epidermal psoriasiform [[hyperplasia]]
* Marked intercellular [[edema]] with spongiotic vesiculation
* Marked intercellular [[edema]] with spongiotic vesiculation
| align="center" style="background:#F5F5F5;" |
* Blleeding: severe thrombocytopenia,
* Eczema - similar to atopic dermatitis
* Recurrent sino-pulmonary infections
* Opportunistic infections.
* Autoimmune diseases
* Malignancies
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* ↑ serum immunoglobulin A (IgA) levels
* ↑ serum immunoglobulin A (IgA) levels
Line 538: Line 538:
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | Rare, begin in infancy  
| align="center" style="background:#F5F5F5;" | Rare, begin in infancy  
| align="center" style="background:#F5F5F5;" |
* Cold abscesses
* Pruritic eczema
* Allergic diseases
* Noneruption of permanent teeth
* Multiple bone fractures and scoliosisis
* Peripheral T-cell lymphoma
* Coronary artery aneurysms
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 573: Line 564:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Eosinophil-rich infiltration around the hair follicles
* Eosinophil-rich infiltration around the hair follicles
| align="center" style="background:#F5F5F5;" |
* Cold abscesses
* Pruritic eczema
* Allergic diseases
* Noneruption of permanent teeth
* Multiple bone fractures and scoliosisis
* Peripheral T-cell lymphoma
* Coronary artery aneurysms
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*  
*  
Line 582: Line 582:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | Mean age is  55- 60 years
| align="center" style="background:#F5F5F5;" | Mean age is  55- 60 years
| align="center" style="background:#F5F5F5;" |
* Increased risk of :
** Severe viral and bacterial infections
** Secondary malignancies, especially lymphomas
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 613: Line 608:
* Epidermis is spared or has minimal spongiosis
* Epidermis is spared or has minimal spongiosis
* Band-like dermal infiltrate of lymphocytes and and histiocytes
* Band-like dermal infiltrate of lymphocytes and and histiocytes
| align="center" style="background:#F5F5F5;" |
* Increased risk of :
** Severe viral and bacterial infections
** Secondary malignancies, especially lymphomas
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Staging of Mycosis fungoides is based upon:
* Staging of Mycosis fungoides is based upon:
Line 628: Line 627:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated factors
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/
Multiple
Multiple
Line 641: Line 639:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated factors
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
|}
|}

Revision as of 15:06, 25 October 2018

Atopic dermatitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atopic dermatitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Atopic dermatitis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atopic dermatitis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atopic dermatitis differential diagnosis

CDC on Atopic dermatitis differential diagnosis

Atopic dermatitis differential diagnosis in the news

Blogs onAtopic dermatitis differential diagnosis

Directions to Hospitals Treating Atopic dermatitis

Risk calculators and risk factors forAtopic dermatitis differential diagnosis


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Differentiating Atopic Dermatitis from other Diseases

Category Diseases Etiology Inherited Acquired Clinical manifestations Para-clinical findings Associated factors Additional findings
Demography Symptoms Physical examination
Lab Findings Histopathology
Appearance Itching Fever Tenderness Other CBC Serum IgE
Single/

Multiple

Rash Involved areas Pustule WBC
Skin disorders Atopic dermatitis
  • Epidermal barrier dysfunction
  • Immune dysregulation
+ +
  • Incidence is highest during infancy and early childhood.
Multiple
  • Young children -Scalp, cheeks amd extensor surface
  • Adolescents -flexural areas and buttock-thigh creases
  • Adults - facial involvement and skin flexures
+
  • Infra-auricular and retro-auricular fissuring
  • Nipple eczema
  • White dermographism
  • Perifollicular accentuation
Nl to ↑

(Eosinophilia)

  • Epidermal psoriasiform hyperplasia
  • Marked intercellular edema with spongiotic vesiculation
  • Hayfever
  • Asthma
Allergic contact dermatitis[1]
  • Delayed-type hypersensitivity response
  • Skin inflammation mediated by hapten-specific T cells
+ Any May be multiple after 1-2 days of exposure Erythematous well-demarcated papules Surrounding the area in contact with the offending agent + +
  • Stinging and burning
  • Localized swelling
  • Lichenified pruritic plaques
Nl to ↑

(Eosinophilia)

Nl NA
  • Contact with allergens in the past 1-2 days
  • Positive family history
  • Prevention by avoidance
Irritant contact dermatitis[2]
  • Activation of the innate immune system by the pro-inflammatory properties of chemicals
+ Any, more occupational exposure Usually single immediately after the exposure Well-demarcated red patch with a glazed surface Any area in contact with the irritant + +
  • Swelling, blistering and scaling of the damaged area
  • Dryness
  • Thicker skin
Nl Nl
  • Spongiosis
  • Intraepidermal vesicles or bullae
  • Necrosis of keratinocytes
  • Cumulative exposure to irritants
  • Negative hypersensitivity tests
Seborrheic dermatitis
  • Not known
+ Any, onset during the infancy and peak during 3rd-4th decades Multiple
  • Cradle cap - yellowish scales on the scalp
  • Patchy or diffuse greasy scaling with or without a yellow-red base
  • Crusts
Scalp, face, trunk, postauricular, diaper area and axilla + +
  • Infants:
    • Craddle cap (Sclap) - non-inflammatory greasy scales on the scalp
    • Asymptomatic
    • Self resolving
Nl Nl
  • Focal parakeratosis and spongiosis in epidermis
  • Psoriasiform hyperplasia
  • Neutrophils at the margins
  • Stress
  • Cold, dry weather can cause flare ups
  • Super infection with bacteria and candida
  • Generalized seborrheic erythroderma in immunodeficient patients
Psoriasis
  • Keratinocyte hyperproliferation
  • Dysregulation of the immune system
+ + Any, 2 peaks of onset 30-39 years and 50-59 years Multiple Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales
  • Scalp
  • Trunk
  • Gluteal cleft
  • Extensor surface of elbows and knees
+ + _ +
  • Auspitz sign (pinpoint bleeding)
  • Smoking
  • Skin trauma
  • Alcohol abuse
  • Stress
  • Cold weather
  • Vitamin D deficiency
  • Drugs
Lichen simplex [3]chronicus
  • Lichenified plaques and excoriations of lichen simplex chronicus develop secondary to extensive pruritus due to other conditions such as atopic dermatitis, neuropathic pruritus, etc
+ Any, peak at 30-50 years of age Multiple Lichenified and erythematous, pruritic exudative plaque, and excoriations Scalp, head, neck, hands, arms, and genitals areas +
  • Color of plaque varies fro, yellow to reddish brown
  • Plaque size can vary between 3X6 cm 6X10 cm areas.
Nl Nl
  • Markedly hyperplastic epidermis
  • Irregular hyperkeratosis and parakeratosis
  • Thick granular zone
  • Acanthosis
  • Emotional stress
  • Sleep disturbances
  • Dry weather
  • Sweating
  • Excessive dryness
  • Sexual dysfunction
  • Sleep disturbances
  • Depression
  • Dissociative disturbances
Ichthyosis vulgaris[4]
  • Loss of function mutations in the filaggrin gene (FLG)
  • Autosomal dominant inheritance with incomplete penetrance
+ + Usually in infancy Multiple
  • Xerosis and gray scaling
  • Palmar hyperlinearity
  • Keratosis pilaris
  • Extensor surfaces of the extremities
  • Scalp
  • Trunk
  • Scales can vary from mild scaling to large, plate (armor)-like scales and thickening of the skin.
Nl Nl
  • Reduced keratohyalin granules
  • Perinuclear keratin retractions in granular cells
  • Thick stratum corneum
  • Basket-weave pattern of stratum corneum
  • Dry and cold weather
  • Increased risk of atopic diseases including asthma, alllergic rhinitis and atopic dermatitis
  • Increased risk for atopy, including asthma, allergies, and atopic dermatitis
Nummular dermatitis (discoid eczema) Unknown + Any, two peaks, 6th-7th decade of life in males and 2nd-3rd decade of life in females Multiple Nl
  • Upper extremities
  • Lower extremities
  • Lower trunk
+
  • Chronically lesions result into central clearing leading to annular lesions.
Nl Nl
  • Spongiosis
  • Perivascular lymphocytic infiltrates, with eosinophils and occasional neutrophils
  • Temperature changes (particularly winter)
  • Emotional stress
  • Dry skin
  • Environmental irritants
  • Recent surgery
  • Medications like topical antibiotic creams and isotretinoin
  • Superinfection with staphylococcus aureus
Netherton's syndrome[5] Autosomal recessive mutations in the serine protease inhibitor of Kazal type 5 gene (SPINK5), encoding LEKTI, a serine protease inhibitor + Affects neonates Multiple
  • Classic triad
    • Congenital ichthyosiform erythroderma
    • Trichorrhexis invaginata
    • Allergic diseases with elevated serum levels of immunoglobulin
  • Ichthyosis linearis circumflexa (ILC) - serpiginous migratory pink-red plaques with double-edged scale at the margins
  • Diffuse pattern
  • Axillae,
  • Hair
  • Inguinal folds
  • Gluteal cleft
  • Groin
  • Lower legs
+ +
  • Trichorrhexis invaginata (hair involvement):
    • Sparse, short, spike and brittle
    • "Bamboo hair" or "ball and socket deformity" of hair and eyebrows
    • Nodes along the hair shaft
Nl to ↑

(Eosinophilia)

  • psoriasiform hyperplasia
  • Reduced granular layer
  • Dyskeratosis,
  • Dermal inflammatory infiltrate including neutrophils and eosinophils
  • Atopic diseases including food allergy and strong family history of asthma, atopic dermatitis and allergic rhinitis
    • Systemic and skin superinfections
    • Failure to thrive
    • Electrolyte imbalances, including hypernatremic dehydration
    • Atopic diseases
Diseases Etiology Inherited Acquired Demography Single/

Multiple

Rash Involved areas Pustule Itching Fever Tenderness Other WBC ESR/CRP Histopathology Associated factors Additional findings
Infection Dermatophytes
Molluscum contagiosum Molluscum contagiosum virus inoculation through direct skin contact + Any, peak among children >5 years of age and young adults Multiple
  • Flesh-colored, dome-shaped papules with a central umbilication
  • Lesions are 2-5mm in diameter
  • Face, trunk, antecubital, popliteal fossae and groin
+ If molluscum contagiosum is acquired as sexually transmitted disease, it involves, groin and genital region. Nl Nl
  • Keratinocytes containing eosinophilic inclusion bodies (Henderson-Paterson bodies)
  • H&E stain - inwards indentation of the epidermis
  • Often asymptomatic
  • Tender or pruritic skin lesions
  • Self resolve within 2 months
  • Immunocompetent patients present with extensive and severe infections
mMlluscum contagiosum

lesions on the eyelid may lead to follicular or papillary conjunctivitis .

Scabies Multiple Erythematous papular lesions Flexor wrists, finger webs and genitalia +++
  • Positive family history
Immunologic disorders Dermatitis herpetiformis[6] Autoimmune disorder as a result of gluten sensitivity leading to the formation of IgA antibodies + Any, mean age of disease onset is 2nd-4th decade Multiple
  • Excoriated papules or plaques and vesicles arranged in a clustered fashion
  • Symmetrical
  • Erosions and excoriations
  • Extensor surfaces including arms, knees, and buttocks.
+
  • Oral manifestation such as vesicles and erosion may be present
Nl Nl
  • Papillary micro-abscesses
  • Sub-epidermal blisters containing neutrophils, eosinophils, and fibrin
  • Sub-epidermal vacuolization
  • Intermittent pruritic papules and vesicles
  • Associated small intestine celiac disease with villous atrophy and crypt hyperplasia
  • Abdominal bloating, pain, diarrhea, or constipation
Immune deficiency Wiskott-Aldrich syndrome[7]
  • Mutation in the gene encoding for Wiskott-Aldrich syndrome protein (WASp) on the short arm of the X chromosome
  • X-linked disorder
+ Seen almost exclusively in males in infancy Multiple
  • Rash is clinically similar to atopic dermatitis
  • Erythematous and pruritic lesions
  • Lesions can bleed due to thrombocytopenia
  • Cutaneous manifestations includes petechiae and ecchymosis
Rash can involve lesions located at the same areas of classical atopic dermatitis:

extensor surfaces of extremities and cheeks or scalp

+ Infants can present with petechiae, prolonged bleeding from umbilicus or circumcision, purpura, hematemesis, melena, epistaxis, hematuria or unusal bruising Nl to ↑

(Eosinophilia)

  • Epidermal psoriasiform hyperplasia
  • Marked intercellular edema with spongiotic vesiculation
  • Blleeding: severe thrombocytopenia,
  • Eczema - similar to atopic dermatitis
  • Recurrent sino-pulmonary infections
  • Opportunistic infections.
  • Autoimmune diseases
  • Malignancies
  • ↑ serum immunoglobulin A (IgA) levels
  • ↑ serum immunoglobulin E (IgE) levels
  • Thrombocytopenia
Hyper-IgE syndrome[8]
  • Defects in the JAK-STAT signaling pathway leading to dysfunctional T helper cell type 17 (Th17) differentiation
+ Rare, begin in infancy Multiple
  • Papulopustular
  • Severely pruritic eczematous rash
  • Pustular and may impetiginized
  • Lichenification may occur
  • Face and scalp
  • Upper trunk and shoulders
  • Buttocks
  • Area behind the ears and around the hairline
+ +
  • Characteristic coarse facies
  • Increased alar width and broad nasal bridge
  • High-arched oral palate
  • Hyperextensible joints
Nl to ↑

(Eosinophilia)

  • Eosinophil-rich infiltration around the hair follicles
  • Cold abscesses
  • Pruritic eczema
  • Allergic diseases
  • Noneruption of permanent teeth
  • Multiple bone fractures and scoliosisis
  • Peripheral T-cell lymphoma
  • Coronary artery aneurysms
Malignancy Mycosis fungoides Clonal expansion of CD4+ memory T cells (CD45RO+) + Mean age is 55- 60 years Multiple
  • Non pruritic patches and intensely pruritic plaques
  • Comedones, cysts
  • Tumors of skin
  • Erythematous macules
  • Hypopigmented patches
  • Asymmetrical
  • Hips, groin and trunk
+
  • Alopecia
  • Acneiform lesions
  • Plaques size can vary between 2-20 cm
  • Lymphadenopathy
  • Children- hypopigmented patches most common
Nl Nl
  • Perifollicular infiltrates around the infundibulum
  • Epidermis is spared or has minimal spongiosis
  • Band-like dermal infiltrate of lymphocytes and and histiocytes
  • Increased risk of :
    • Severe viral and bacterial infections
    • Secondary malignancies, especially lymphomas
  • Staging of Mycosis fungoides is based upon:
    • Patches
    • Plaques
    • Skin tumors
    • Lymphadenopathy
    • Erythroderma
    • Histology
Category Diseases Etiology Inherited Acquired Demography Single/

Multiple

Rash Involved areas Pustule Itching Fever Tenderness Other WBC ESR/CRP Histopathology Associated factors Additional findings

References

  1. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.
  2. Bains SN, Nash P, Fonacier L (October 2018). "Irritant Contact Dermatitis". Clin Rev Allergy Immunol. doi:10.1007/s12016-018-8713-0. PMID 30293200.
  3. Voicu C, Tebeica T, Zanardelli M, Mangarov H, Lotti T, Wollina U, Lotti J, França K, Batashki A, Tchernev G (July 2017). "Lichen Simplex Chronicus as an Essential Part of the Dermatologic Masquerade". Open Access Maced J Med Sci. 5 (4): 556–557. doi:10.3889/oamjms.2017.133. PMC 5535688. PMID 28785363.
  4. Thyssen JP, Godoy-Gijon E, Elias PM (June 2013). "Ichthyosis vulgaris: the filaggrin mutation disease". Br. J. Dermatol. 168 (6): 1155–66. doi:10.1111/bjd.12219. PMID 23301728.
  5. Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafé JL, Wilkinson J, Taïeb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A (June 2000). "Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome". Nat. Genet. 25 (2): 141–2. doi:10.1038/75977. PMID 10835624.
  6. Kárpáti S (2012). "Dermatitis herpetiformis". Clin. Dermatol. 30 (1): 56–9. doi:10.1016/j.clindermatol.2011.03.010. PMID 22137227.
  7. Buchbinder D, Nugent DJ, Fillipovich AH (2014). "Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments". Appl Clin Genet. 7: 55–66. doi:10.2147/TACG.S58444. PMC 4012343. PMID 24817816.
  8. Mogensen TH (April 2013). "STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties". JAKSTAT. 2 (2): e23435. doi:10.4161/jkst.23435. PMC 3710320. PMID 24058807.


Template:WikiDoc Sources